Promea Therapeutics Private Limited - Company Profile

It is a healthcare private limited company based in Patancheru, Telangana, India, established in 2017.
2017 Patancheru, Telangana, India Active
Last Updated:
Access Report
About Promea Therapeutics Private Limited

Promea Therapeutics Private Limited, a active private limited company, was established on 31 July 2017 in Patancheru, Telangana, India. Engaging in medical & laboratory equipment within the manufacturing sector, it holds CIN: U24304TG2017PTC118617. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹4.00 Cr and a paid-up capital of ₹3.86 Cr.

It upholds a compliant status. Employing 174 professional, Its leadership includes Rajesh Reddy Tummuru (Director), Pooja Aakanksha Gaddam (Director). Past directors included Gaddam Reddy Ranjith. It holds ₹58.19 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No. M4, Medical Device Park, Sultanpur (V), Patancheru, Telangana, 502319.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24304TG2017PTC118617

  • Registration Number

    118617

  • Incorporation Date

    31 July 2017

  • Authorized Capital

    ₹4.00 Cr

  • Paid-Up Capital

    ₹3.86 Cr

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 4.00 Cr
  • Paid Up Capital ₹ 3.86 Cr
  • Company Age 8 Year, 6 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 58.19 Cr
  • Revenue Growth **** 98.06%
  • Profit Growth **** -17198.90%
  • Ebitda **** 225.23%
  • Net Worth -28.66%
  • Total Assets **** 24.16%
Company report

Promea Therapeutics Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Promea Therapeutics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Promea Therapeutics Private Limited?
Current Directors
Name Designation Appointment Date Status
Rajesh Reddy Tummuru Director 09 Oct 2017 Current
Pooja Aakanksha Gaddam Director 31 Jul 2017 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 27 Sep 2018 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Promea Therapeutics.

Promea Therapeutics Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 98.06% increase. The company also saw a substantial fall in profitability, with a 17198.9% decrease in profit. The company's net worth observed a substantial decline by a decrease of 28.66%.

Promea Therapeutics revenue growth over time
Promea Therapeutics profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 98.06%
*******
*******
*******
*******
Revenue from Operations
*******
 99.65%
*******
*******
*******
*******
Total Assets
*******
 24.16%
*******
*******
*******
*******
Profit or Loss
*******
 -17198.90%
*******
*******
*******
*******
Net Worth
*******
 -28.66%
*******
*******
*******
*******
EBITDA
*******
 225.23%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Promea Therapeutics?

Unlock access to Promea Therapeutics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹581,940,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Others : 56.16 Cr
  • Axis Bank Limited : 2.03 Cr
Latest Charge Details
Date Lender Amount Status
11 Jun 2025 Axis Bank Limited ₹2.80 M Open
01 Jul 2024 Others ₹36.08 Cr Open
29 Dec 2022 Axis Bank Limited ₹1.75 Cr Open
24 May 2021 Others ₹20.08 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Promea Therapeutics?

Promea Therapeutics has a workforce of 174 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Promea Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Promea Therapeutics's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Promea Therapeutics
Recent Activity within the Organization
  • Annual General Meeting

    The activity Promea Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Charges

    The activity A charge with Axis Bank Limited amounted to Rs. 0.28 Cr with Charge ID 101180880 was registered on 11 Jun 2025. was completed.

  • Charges

    Progress on A charge with Others of Rs. 36.08 Cr registered on 01 Jul 2024 with Charge ID 100955463 was modified on 28 May 2025. was documented.

  • Balance Sheet

    Progress on Promea Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was documented.

  • Charges

    Progress on A charge with Others of Rs. 20.08 Cr registered on 24 May 2021 with Charge ID 100470484 was modified on 30 Jan 2025. was documented.

  • Charges

    Progress on A charge with Others amounted to Rs. 36.08 Cr with Charge ID 100955463 was registered on 01 Jul 2024. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Promea Therapeutics Private Limited?

The CIN of Promea Therapeutics Private Limited is U24304TG2017PTC118617.

Where is Promea Therapeutics Private Limited headquartered?

Promea Therapeutics Private Limited is headquartered at Plot No. M4, Medical Device Park, Sultanpur (V), Patancheru, Telangana, 502319.

When was Promea Therapeutics Private Limited incorporated?

Promea Therapeutics Private Limited was incorporated on 31 July 2017.

Who are the current directors of Promea Therapeutics Private Limited?

The current directors of Promea Therapeutics Private Limited are

What is the primary industry of Promea Therapeutics Private Limited?

The primary industry of Promea Therapeutics Private Limited is Manufacturing.

Is Promea Therapeutics Private Limited a listed company?

Promea Therapeutics Private Limited is unlisted.

What is the capital structure of Promea Therapeutics Private Limited?

The authorized capital of Promea Therapeutics Private Limited is ₹4.00 Cr, and the paid-up capital is ₹3.86 Cr.

What is the compliance status of Promea Therapeutics Private Limited?

The compliance status of Promea Therapeutics Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available